Please login to the form below

Not currently logged in
Email:
Password:

anaemia

This page shows the latest anaemia news and features for those working in and with pharma, biotech and healthcare.

Celgene’s Revlimid gets a win in late-stage lymphoma

Celgene’s Revlimid gets a win in late-stage lymphoma

Celgene is planning to file for approval of Revlimid in the new indication early next year, adding to its current uses in multiple myeloma, mantle cell lymphoma, and anaemia associated with

Latest news

More from news
Approximately 9 fully matching, plus 147 partially matching documents found.

Latest Intelligence

  • Leo has its eyes on the prize Leo has its eyes on the prize

    major depressive disorder and iron-deficiency anaemia.

  • Deal Watch - May 2017 Deal Watch - May 2017

    It is not known why in December 2015 the territorial rights granted to Mitsubishi for vadadustat for treatment of anaemia, were limited to Japan, SE Asia and India. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in

  • Deal Watch December 2016 Deal Watch December 2016

    1, 000. Akebia (US). Otsuka (Japan). Licence (US). Vadadustat: oral hypoxia-inducible factor (HIF) stabiliser in phase III for anaemia of chronic kidney disease.

  • Focusing on value Focusing on value

    in Brazil, involving the iron deficiency related anaemia treatment Anemidox/Confer and liver protector Hepabionta. “

  • Deal Watch February 2016 Deal Watch February 2016

    licence. 105. †† Genexine/ Shanghai Chemo WanBang Biopharma. GX-E2 (EPO-hyFc), a novel Fc-engineered (hyFc) long acting EPO, for anaemia due to chronic kidney disease and chemotherapy. ... investment. 42.5. ††† Rockwell Medical Technologies/

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Joined-up thinking on anaemia

    Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’ s quality of life, but it’ s often under-treated. ... Pharmacosmos is committed to improving the lives of patients with iron deficiency anaemia

  • Joined-up thinking on anaemia

    Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’ s quality of life, but it’ s often under-treated. ... Pharmacosmos is committed to improving the lives of patients with iron deficiency anaemia

  • Living with Crohn's disease: a patient perspective

    It’ s also a very individual condition. The most common symptoms are not only diarrhoea, but also tiredness and fatigue, abdominal pain, mouth ulcers, anaemia, loss of appetite, and weight loss.

  • Patient Power: Too Much of a Good Thing?

    It commonly causes abdominal pain, diarrhoea, weight loss and vomiting but because it affects the immune system it can cause other problems such as anaemia, arthritis, lack of concentration, tiredness and

  • FCB Halesway

    Pain relief. Hospira. Anaemia. Neutropenia. Rheumatology. Dermatology. Gastroenterology. Lincoln Medical. Anaphylaxis.

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics